Affordable Access

Access to the full text

First laser ions at the CERN-MEDICIS facility

Authors
  • Gadelshin, Vadim Maratovich1, 2
  • Wilkins, Shane3
  • Fedosseev, Valentin Nikolaevich3
  • Barbero, Ermanno3
  • Barozier, Vincent3
  • Bernardes, Ana-Paula3
  • Chevallay, Eric3
  • Cocolios, Thomas Elias4
  • Crepieux, Bernard3
  • Dockx, Kristof4
  • Eck, Matthias1
  • Fernier, Pascale3
  • Cavaier, Roberto Formento5
  • Haddad, Ferid6, 7
  • Jakobi, Johannes1
  • Lambert, Laura3
  • Marsh, Bruce Allan3
  • Marzari, Stefano3
  • Ramos, Joao Pedro3, 4
  • Moberg, Annie Ringvall3, 8
  • And 6 more
  • 1 Johannes Gutenberg-Universität, Mainz, 55128, Germany , Mainz (Germany)
  • 2 Ural Federal University, Yekaterinburg, 620002, Russia , Yekaterinburg (Russia)
  • 3 CERN, Geneva, 1211, Switzerland , Geneva (Switzerland)
  • 4 KU Leuven, Leuven, 3001, Belgium , Leuven (Belgium)
  • 5 A Novartis Company, Colleretto Giacosa/Ivrea, 10010, Italy , Colleretto Giacosa/Ivrea (Italy)
  • 6 GIP ARRONAX, Nantes, France , Nantes (France)
  • 7 Nantes University, Nantes, France , Nantes (France)
  • 8 Gothenburg University, Gothenburg, Sweden , Gothenburg (Sweden)
Type
Published Article
Journal
Hyperfine Interactions
Publisher
Springer International Publishing
Publication Date
May 06, 2020
Volume
241
Issue
1
Identifiers
DOI: 10.1007/s10751-020-01718-y
Source
Springer Nature
Keywords
License
Green

Abstract

The CERN-MEDICIS facility aims to produce emerging medical radionuclides for the theranostics approach in nuclear medicine with mass separation of ion beams. To enhance the radioisotope yield and purity of collected samples, the resonance ionization laser ion source MELISSA was constructed, and provided the first laser ions at the facility in 2019. Several operational tests were accomplished to investigate its performance in preparation for the upcoming production of terbium radioisotopes, which are of particular interest for medical applications.

Report this publication

Statistics

Seen <100 times